JP2002502828A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002502828A5 JP2002502828A5 JP2000530233A JP2000530233A JP2002502828A5 JP 2002502828 A5 JP2002502828 A5 JP 2002502828A5 JP 2000530233 A JP2000530233 A JP 2000530233A JP 2000530233 A JP2000530233 A JP 2000530233A JP 2002502828 A5 JP2002502828 A5 JP 2002502828A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- molecule
- hbsag
- particles
- antigenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 7
- 239000002245 particle Substances 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000004044 response Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7347698P | 1998-02-03 | 1998-02-03 | |
| US60/073,476 | 1998-02-03 | ||
| PCT/IL1999/000060 WO1999039736A2 (en) | 1998-02-03 | 1999-01-29 | DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002502828A JP2002502828A (ja) | 2002-01-29 |
| JP2002502828A5 true JP2002502828A5 (enExample) | 2006-01-26 |
| JP4480267B2 JP4480267B2 (ja) | 2010-06-16 |
Family
ID=22113916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000530233A Expired - Fee Related JP4480267B2 (ja) | 1998-02-03 | 1999-01-29 | ＨＢｓＡｇ粒子を介する免疫原性分子の送達 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1053018B1 (enExample) |
| JP (1) | JP4480267B2 (enExample) |
| AT (1) | ATE300312T1 (enExample) |
| AU (1) | AU755957B2 (enExample) |
| CA (1) | CA2319599C (enExample) |
| DE (1) | DE69926342T2 (enExample) |
| DK (1) | DK1053018T3 (enExample) |
| ES (1) | ES2242376T3 (enExample) |
| WO (1) | WO1999039736A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ912000A0 (en) * | 2000-07-31 | 2000-08-24 | Crown In The Right Of The Queensland Department Of Health, The | Improved virus like particles |
| DE10106235A1 (de) * | 2001-02-10 | 2002-08-22 | Bosch Gmbh Robert | Wischarm |
| KR20060015534A (ko) | 2003-04-25 | 2006-02-17 | 더 펜 스테이트 리서치 파운데이션 | 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템 |
| CU23405A1 (es) * | 2003-10-20 | 2009-08-04 | Ct Ingenieria Genetica Biotech | Composiciones farmacéuticas para uso terapéutico |
| PL1802746T3 (pl) | 2004-10-27 | 2011-10-31 | Crucell Switzerland Ag | Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B |
| JP2009120532A (ja) * | 2007-11-14 | 2009-06-04 | Osaka Univ | 糖及び糖鎖認識機構を利用する物質送達用及びバイオイメージング用バイオナノカプセル |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5039522A (en) * | 1988-01-29 | 1991-08-13 | New York Blood Center, Inc. | Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis B virus surface antigen |
| JP2001526688A (ja) * | 1997-05-19 | 2001-12-18 | メルク エンド カンパニー インコーポレーテッド | オリゴヌクレオチドアジュバント |
-
1999
- 1999-01-29 DE DE69926342T patent/DE69926342T2/de not_active Expired - Lifetime
- 1999-01-29 CA CA2319599A patent/CA2319599C/en not_active Expired - Fee Related
- 1999-01-29 JP JP2000530233A patent/JP4480267B2/ja not_active Expired - Fee Related
- 1999-01-29 EP EP99902800A patent/EP1053018B1/en not_active Expired - Lifetime
- 1999-01-29 WO PCT/IL1999/000060 patent/WO1999039736A2/en not_active Ceased
- 1999-01-29 AT AT99902800T patent/ATE300312T1/de not_active IP Right Cessation
- 1999-01-29 ES ES99902800T patent/ES2242376T3/es not_active Expired - Lifetime
- 1999-01-29 AU AU22973/99A patent/AU755957B2/en not_active Ceased
- 1999-01-29 DK DK99902800T patent/DK1053018T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002516292A5 (enExample) | ||
| AU7877900A (en) | Method of obtaining cellular immune responses from proteins | |
| JP2009102327A (ja) | パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法 | |
| DK0454044T3 (da) | Farmakologisk præparat indeholdende polyelektrolytkomplekser på mikropartikelform og mindst et virksomt stof | |
| AU7921091A (en) | Viral decoy vaccine | |
| JP2001523729A5 (enExample) | ||
| AU4322996A (en) | Variants of human papilloma virus antigens | |
| CA2272245A1 (en) | Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies | |
| DE69930630D1 (de) | B2microglobulin fusionsproteine und varianten mit hoher affinität | |
| JP2004512264A5 (enExample) | ||
| ATE249240T1 (de) | Strategisch modifizierte hepatitis b kernproteine und ihre derivate | |
| JP2004501618A5 (enExample) | ||
| WO1998055495A3 (en) | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof | |
| CA2288958A1 (en) | Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation | |
| JP2005527470A5 (enExample) | ||
| JP2002501033A5 (enExample) | ||
| JP2003515569A5 (enExample) | ||
| Gilligan et al. | Oral vaccines: design and delivery | |
| CA2014033A1 (en) | Compositions and treatments for pneumonia in animals | |
| NZ505876A (en) | Solid nanosphere composition and delivery of a coacervate polymeric cation (gelatine or chitosan) and a polyanion (nucleic acids) | |
| DE69933875D1 (de) | Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt. | |
| JPH1135456A5 (enExample) | ||
| CA2252374A1 (en) | A process for viral inactivation of lyophilized blood proteins | |
| JP2000236877A5 (enExample) | ||
| CA2319599A1 (en) | Delivery of immunogenic molecules via hbsag particles |